RecruitingNCT06733740
Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma
The Clinical Outcomes of Ultrasound-guided Thermal Ablation for the Treatment of Papillary Thyroid Carcinoma: A Multicenter Study
Sponsor
Chinese PLA General Hospital
Enrollment
3,000 participants
Start Date
Dec 10, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To evaluate long-term outcomes of ultrasound-guided thermal ablation for the treatment of papillary thyroid carcinoma
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- patients age between 18 and 80 year old, both sex
- papillary thyroid carcinoma confirmed by core-needle biopsy or fine-needle aspiration
- the largest diameter ≤2.0 cm
- no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, neck and chest CT
- follow-up period ≥12 months
Exclusion Criteria4
- patients with convincing evidence of aggressive papillary thyroid carcinoma or other type of thyroid cancer by biopsy
- history of neck radiation
- coagulation disorder, serious heart, respiratory, liver, or renal failure
- dysfunction of the vocal cord on the opposite side
Interventions
PROCEDUREultrasound-guided thermal ablation
ultrasound-guided thermal ablation to treat tumor
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06733740
Related Trials
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
NCT071407571 location
Studies on Tumors of the Thyroid
NCT000011601 location
Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples
NCT061333741 location
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
NCT050249299 locations
A Study of Online Follow-up in Patients With Papillary Thyroid Cancer
NCT068004821 location